Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
5.11
-0.16 (-3.04%)
At close: Feb 21, 2025, 4:00 PM
4.850
-0.260 (-5.09%)
After-hours: Feb 21, 2025, 7:52 PM EST
Aclarion Employees
As of December 31, 2023, Aclarion had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$8,215
Profits / Employee
-$1,046,807
Market Cap
5.19M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6 | -1 | -14.29% |
Dec 31, 2022 | 7 | 1 | 16.67% |
Dec 31, 2021 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ACON News
- 2 days ago - Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit - GlobeNewsWire
- 11 days ago - Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body - GlobeNewsWire
- 16 days ago - Aclarion Announces Northwestern Medicine as First CLARITY Trial Site - GlobeNewsWire
- 18 days ago - Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded - GlobeNewsWire
- 3 months ago - Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash - GlobeNewsWire
- 3 months ago - Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st - Accesswire
- 4 months ago - Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 5 months ago - Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes - GlobeNewsWire